Abbares Pharmaceuticals Private Limited, a active private limited company, was established on 31 March 2018 in Jodhpur, Rajasthan, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909RJ2018PTC060761. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Rajesh Bhardwaj (Director), Preksha Bhardwaj (Director), Seema Bhardwaj (Director). Past directors included Subodh Saxena, Preksha Bhardwaj. It holds ₹4.23 Cr open charges and ₹4.47 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Villa No 14 Umaid Haritage,Ratanada, Jodhpur, Rajasthan, 342011.
U51909RJ2018PTC060761
060761
31 March 2018
₹1.00 M
₹1.00 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Abbares Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Bhardwaj | Director | 31 Mar 2018 | Current |
| Preksha Bhardwaj | Director | 15 Jun 2019 | Current |
| Seema Bhardwaj | Director | 01 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Abbares Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.96% increase. The company also saw a slight decrease in profitability, with a 0.49% decrease in profit. The company's net worth Soared by an impressive increase of 25.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Abbares Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹42,306,496.00
₹44,682,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2023 | Others | ₹3.50 Cr | Open |
| 18 Oct 2022 | Others | ₹6.80 M | Open |
| 21 Dec 2021 | Hdfc Bank Limited | ₹0.51 M | Open |
| 30 Sep 2022 | Others | ₹2.97 Cr | Satisfied |
| 29 Jan 2021 | Hdfc Bank Limited | ₹1.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Abbares Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Abbares Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbares Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Abbares Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Abbares Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was recorded as a recent event.
Progress on A charge registered on 23 Jan 2019 via Charge ID 100239394 with Others was fully satisfied on 15 Mar 2024. was documented.
Progress on A charge with Others of Rs. 35.00 M registered on 20 Nov 2023 with Charge ID 100844174 was modified on 01 Mar 2024. was documented.
Progress on A charge registered on 30 Sep 2022 via Charge ID 100618580 with Others was fully satisfied on 27 Feb 2024. was documented.
A charge registered on 29 Jan 2021 via Charge ID 100420556 with Hdfc Bank Limited was fully satisfied on 02 Feb 2024. was recorded as a recent event.
The CIN of Abbares Pharmaceuticals Private Limited is U51909RJ2018PTC060761.
Abbares Pharmaceuticals Private Limited is headquartered at Villa No 14 Umaid Haritage,Ratanada, Jodhpur, Rajasthan, 342011.
Abbares Pharmaceuticals Private Limited was incorporated on 31 March 2018.
The current directors of Abbares Pharmaceuticals Private Limited are
The primary industry of Abbares Pharmaceuticals Private Limited is Trade.
Abbares Pharmaceuticals Private Limited is unlisted.
The authorized capital of Abbares Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX